Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol: ULVR.LSE
Batch: 7
Published: September 20, 2026
AI Advisors: 14

Historical AI Consensus Investment Thesis

Unilever (ULVR) Stock Forecast and AI Rating

Deep analysis published Sep 21 2026Original pricing snapshot Sep 18 2026

Publisher

Russlan Ramdowar

12 min read

Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

BUY

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

NEUTRAL

4,774 GBX

+3.3%+6.8% incl. dividends

2031

5-Year

BUY

6,599 GBX

+42.8%+68.8% incl. dividends

Published batch insight

Radical Portfolio Carveouts Transform Consumer Giant Into High Margin Cash Compounder

Sharp divergence defines the analytical outlook following major portfolio unbundling. While high consensus confirms widening operating margins and robust emerging market volume growth across core personal care franchises, models split sharply over whether the pending foods separation dilutes the quoted equity series or unlocks accelerated shareholder returns.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

J.P. Morgan (Titan), Universal Investor (Polymath), Superintelligence (Anthropologist), Elon Musk (Visionary), Ray Dalio (Strategist), Machiavelli (Insider), Warren Buffett (Value Purist), Michael Burry (Vulture), Sherlock Holmes (Whistleblower). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models

Gemini

Claude

ChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in Unilever at the forecast anchor (2026-09-18): $16,663 in five years versus $13,892 for S&P 500 benchmark.

Unilever · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 3.4% net dividend yield for Unilever.

Figure: Five-year synthesized consensus value path for Unilever compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.

20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView table

Frozen forecast from 18 Sept 2026. Prices in GBX; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 4,621 GBX1-year price return: +3.31%5-year price return: +42.82%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in GBX, with returns and rationale
Quarter	Target (GBX)	Quarter return	Total return	Forecast rationale
Q4 2026	4,669.98	+1.06%	+1.06%	Year-end trading confirms underlying volume resilience across Beauty and Personal Care, absorbing commodity inflation. Cautious sentiment persists amid restrictive sovereign bond yields and preliminary UK regulatory scrutiny over the Foods divestment, keeping equity gains measured.
Q1 2027	4,808.21	+2.96%	+4.05%	Full-year 2026 disclosures validate operating margins near twenty percent and robust cash conversion. Active share repurchases and clarity regarding Foods transaction terms provide positive valuation support, overcoming high interest rate headwinds across European defensive equities.
Q2 2027	4,884.66	+1.59%	+5.71%	Final regulatory approvals for the McCormick transaction approach as first-quarter volumes remain solid in emerging markets. However, market anticipation of transaction mechanics and arbitrage positioning around the pending equity distribution tempers quoted price momentum.
Q3 2027	4,773.78	-2.27%	+3.31%	Foods separation closes via the Reverse Morris Trust, transferring majority combined entity equity directly to shareholders. This corporate unbundling triggers an ex-distribution price adjustment on the quoted series, partially cushioned by fifteen billion dollars in cash proceeds.
Q4 2027	4,901.72	+2.68%	+6.07%	Initial trading as a focused personal care pure-play reveals cleaner segment economics. Substantial cash proceeds accelerate debt paydown and share cancellations under the expanded repurchase program, initiating fundamental equity recovery from the post-distribution low.
Q1 2028	5,027.20	+2.56%	+8.79%	Full-year 2027 financial statements present the first standalone pure-play reporting. Diluted earnings per share stabilize as transitional costs annualize, while a progressive dividend increase reinforces institutional demand for high-quality consumer defensive cash flows.
Q2 2028	5,139.81	+2.24%	+11.23%	Moderating agricultural and energy feedstock costs relieve gross margins across home care. Premium dermatological beauty launches expand distribution across North America and Asia, driving underlying sales growth and supporting solid quarterly equity appreciation.
Q3 2028	5,200.98	+1.19%	+12.55%	Emerging market subsidiaries deliver healthy volume compounding, led by Indian personal care demand. Retail price competition in European grocery channels introduces minor gross margin friction, yet programmatic share buybacks absorb secondary market selling pressure.
Q4 2028	5,340.36	+2.68%	+15.57%	Accelerated share count reduction amplifies per-share owner earnings as global monetary policy begins easing. Defensive positioning ahead of year-end directs institutional capital into dependable consumer staple compounders, generating steady quarter-over-quarter price gains.
Q1 2029	5,478.68	+2.59%	+18.56%	Full-year 2028 results demonstrate operating margins approaching twenty-one percent, validating overhead elimination following portfolio simplification. Pristine free cash flow generation and upgraded guidance prompt sell-side analysts to lift long-term valuation multiples.
Q2 2029	5,590.99	+2.05%	+20.99%	Expansion of digital direct-to-consumer channels improves distribution efficiency and gross margins in premium personal care. Stable emerging market foreign exchange rates reduce translational drag, allowing constant-currency operational gains to flow cleanly into reported earnings.
Q3 2029	5,692.75	+1.82%	+23.19%	Interim disclosures confirm double-digit expansion across clinical skincare acquisitions. Strong cash generation allows self-funded bolt-on investments without leveraging the balance sheet, maintaining positive investor sentiment and supporting steady equity compounding.
Q4 2029	5,791.23	+1.73%	+25.32%	Execution of the multi-year capital return program nears completion, having retired significant equity float. Resilient holiday demand across core hygiene brands protects quarterly turnover, keeping equity valuation firmly supported despite moderate macroeconomic deceleration.
Q1 2030	5,926.75	+2.34%	+28.26%	Full-year 2029 earnings beat expectations as structural productivity gains demonstrate permanence. Management outlines a refreshed multi-year capital allocation framework with enhanced dividends, triggering an institutional re-rating toward specialized personal care peer benchmarks.
Q2 2030	6,041.13	+1.93%	+30.73%	Automated manufacturing nodes and AI-driven supply-chain forecasting lower unit operating costs across core product lines. Favorable volume mix in Southeast Asia compensates for sluggish Western European grocery demand, securing consistent quarterly price performance.
Q3 2030	6,139.00	+1.62%	+32.85%	Steady repeat consumer purchases of daily sanitation essentials preserve volume momentum through late-cycle economic conditions. Lower debt servicing burdens and sustained share repurchases compound underlying earnings per share, driving modest equity gains.
Q4 2030	6,234.77	+1.56%	+34.92%	Year-end balance sheet strength highlights conservative leverage well within investment-grade parameters. Consistent cash conversion covers committed dividend increases and routine share retirements, anchoring equity performance during broader equity market rotations.
Q1 2031	6,371.31	+2.19%	+37.88%	Fiscal 2030 audited accounts confirm sustained return on invested capital above eighteen percent. The equity market permanently removes historical conglomerate discounts, pricing the company on its durable, high-margin consumer health and personal care fundamentals.
Q2 2031	6,477.71	+1.67%	+40.18%	First-half trading exhibits balanced volume and price delivery across core Power Brands. Dependable operating cash flows insulate performance against localized input cost firming, maintaining stable price consolidation and attractive risk-adjusted equity yields.
Q3 2031	6,599.49	+1.88%	+42.82%	The five-year transformation culminates with the enterprise firmly established as an asset-light, high-return personal care leader. Sustained per-share earnings growth and dependable cash distributions solidify terminal equity valuation at normalized historical multiples.

The economic thesis centers on the corporate unbundling of capital-intensive food and ice cream operations into a focused, asset-light personal care enterprise. Sustained volume growth across thirty Power Brands and the delivery of overhead rationalization structurally anchor operating margins near twenty percent. However, equity valuation remains highly sensitive to terminal bond yields and the corporate finance mechanics of the pending Foods separation. The strongest counterargument highlights persistent input cost inflation in surfactants and packaging resins, which risks breaking consumer volume elasticity if retail price increases cannot fully offset upstream commodity volatility.

Key insights

Reverse Morris Trust mechanics transfer substantial equity directly to shareholders, creating an ex-distribution price adjustment on the quoted ticker that masks total returns.
Expanding cash margins in clinical derma and premium beauty decouple earnings from mature grocery channels, reducing enterprise vulnerability to European supermarket discounters.
Massive cash proceeds earmarked for balance-sheet deleveraging and share repurchases will mechanically compress equity float, driving structural per-share cash-flow accretion through 2031.

Deep Dive

Market consensus prices the firm as an uninspiring, low-beta bond proxy constrained by mature European demographics, grocery private-label encroachment, and emerging market currency volatility. External sell-side models anchor heavily on historical low-single-digit top-line growth, treating recent revenue contractions as organic decay while heavily discounting management's ability to sustain volume-led expansion amid elevated energy prices and restrictive global monetary policy.

Paywalled preview begins: Deep Dive

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Alpha Gap & Repricing Catalysts

Where the published AI consensus diverged from the market narrative

Market narrative

Alpha gap

The crowd underestimates value due to an acute analytical misread of corporate perimeter changes. While outside consensus interprets headline top-line contraction as fundamental weakness, forensic evidence demonstrates that unbundling ice cream and foods elevates operating margins toward twenty percent and unlocks fifteen billion dollars in separation cash. The market's blind spot overlooks volume acceleration across thirty prioritized Power Brands and superior emerging-market distribution. This disconnect creates underpricing, though ongoing regulatory review and bond-proxy duration headwinds challenge the speed of rerating.

Repricing catalyst

Regulatory clearance and formal closing of the McCormick Foods combination in mid-2027 will trigger the decisive narrative shift. Receipt of fifteen billion dollars in cash alongside standalone personal-care earnings reporting will dismantle the conglomerate discount. Demonstrating sustained volume growth above three percent while absorbing stranded overhead will force sell-side models to lift forward operating estimates, prompting institutional re-rating toward specialized beauty and personal care peers.

Published consensus context

Macro regime alignment

The macro backdrop represents a mixed setup. Restrictive central bank interest rates and elevated sovereign bond yields act as a duration headwind for defensive consumer proxies. However, non-discretionary hygiene demand and strong pricing power insulate operational cash flows, allowing robust cash generation to provide relative balance-sheet resilience during broader stagflationary pressures.

Published consensus context

Advisor disagreement

The decisive debate centers on the corporate perimeter and valuation mechanics of the Foods separation. Forward-looking models incorporate the forty-five-billion-dollar Reverse Morris Trust combination, anticipating substantial separation cash alongside an ex-distribution price adjustment on the quoted series. In contrast, other analyses overlook the agreed transaction entirely, modeling uninterrupted multiple expansion on unadjusted historical perimeters. A second disagreement concerns input cost resilience: optimists expect gross margins to exceed forty-eight percent via premium brand pricing, whereas skeptics argue that price increases will break emerging market volume elasticity. Audited standalone segment reporting in 2027 will resolve this divergence.

Published scenario analysis

Base-case forces, risks, and opportunities

Top drivers and tailwinds

Power Brands portfolio premiumisation: Concentrating capital behind thirty Power Brands representing over seventy-five percent of turnover accelerates organic growth across personal care and beauty. Superior brand equity allows selective price realization and volume share gains, expanding gross margins toward forty-seven percent. This targeted positioning protects earnings durability and commands higher through-cycle valuation multiples across retail channels. Expected impact: +18%.
Post-demerger structural margin unlocking: Excising capital-intensive cold chains and carving out foods strips away operational bloat, allowing management to realize eight hundred million euros in overhead savings ahead of schedule. Operating margins expanding toward twenty percent reflect streamlined distribution and automated manufacturing networks, permanently lowering fixed expenses and boosting enterprise cash generation through 2031. Expected impact: +15%.
Emerging market demographic volume compounding: Generating nearly sixty percent of turnover across developing economies gives the company an unmatched distribution moat in India, Southeast Asia, and Latin America. Expanding middle-class populations driving personal hygiene penetration generate durable mid-single-digit volume compounding, insulating consolidated revenue from developed-market retail fatigue and supporting sustainable long-term cash generation. Expected impact: +13%.
Disciplined capital return compounding: Generating substantial annual free cash flow allows management to execute recurring share buybacks alongside dependable three-percent dividend growth. Accelerating equity retirements using cash proceeds from portfolio separations mechanically compounds per-share earnings growth. This disciplined capital allocation framework provides downward price support and establishes a dependable compounding floor for patient shareholders. Expected impact: +11%.

Top frictions and headwinds

Upstream petrochemical and packaging inflation: Elevated crude benchmarks and Middle Eastern shipping bottlenecks inflate procurement costs for petrochemical surfactants, plastic packaging resins, and vegetable oils. Passing these feedstock spikes to price-sensitive consumers risks volume elasticity pushback and promotional concessions, temporarily compressing gross margins across home care and nutrition before retail pricing resets fully take effect. Expected impact: -10%.
Emerging market currency depreciation drag: Generating the majority of sales in developing regions exposes reported figures to persistent foreign exchange translation drag against sterling and the euro. Elevated global interest rates and dollar strength drive recurring devaluations across peripheral currencies. While constant-currency operational growth remains sound, translational erosion diminishes reported consolidated turnover and dividend growth. Expected impact: -8%.
Private label encroachment in retail: Persistent household budget fatigue across Europe and North America drives grocery shoppers toward discount store brands in commoditized cleaning and packaged food categories. Retailer private-label expansion constrains shelf pricing power, forcing higher promotional spending and brand advertising to defend market share, which caps operating margin expansion in mature Western markets. Expected impact: -7%.
Transitional stranded overhead and separation costs: Executing major portfolio carveouts creates transitional friction, including hundreds of millions in stranded corporate overhead and multi-year restructuring expenses. Uncoupling complex IT infrastructure, shared services, and global supply agreements temporarily depresses statutory net income, creating an intermediate wedge between underlying operational progress and reported per-share statutory earnings. Expected impact: -6%.

Tail risks

Severe emerging market currency contagion: A synchronized balance-of-payments crisis and severe sovereign debt distress across key emerging economies could trigger acute currency devaluations by late 2027. Squeezed household purchasing power would collapse branded consumer goods volumes, while localized foreign-exchange repatriation controls would slash hard-currency remitted profits, forcing management to curtail capital return programs and impairing equity multiples. Probability: +26%. Expected impact: -20%.
Antitrust block collapses Foods combination: Intensifying competition authority investigations in the UK and Europe could escalate into an intractable regulatory blockage by early 2027, terminating the forty-five-billion-dollar Foods combination. Unilever would lose anticipated cash windfalls, remaining burdened with legacy food overhead. This execution failure would undermine strategic credibility, paralyze capital allocation, and prompt immediate valuation de-rating. Probability: +22%. Expected impact: -18%.

Tail opportunities

Accelerated prestige beauty global expansion: A rapid international rollout of high-margin clinical skincare and prestige wellbeing acquisitions across untapped Asian and Middle Eastern retail channels by 2028 would ignite portfolio mix premiumization. Driven by affluent consumer demand, doubling this division's turnover would lift group gross margins past fifty percent and prompt institutional multiple re-rating toward luxury cosmetic peers. Probability: +32%. Expected impact: +20%.
Surplus cash return post separation: Monetizing retained equity stakes alongside unencumbered cash proceeds from the completed Foods separation could fund an extraordinary ten-billion-euro capital return via special tender offer by 2029. Retiring up to eight percent of outstanding equity would dramatically accelerate diluted per-share earnings growth and trigger immediate upward multiple convergence. Probability: +30%. Expected impact: +16%.

What to monitor

Thesis watchpoints

-- Underlying volume growth sustaining above 2.5% across Power Brands through mid-2027 confirms pricing power and brand market share resilience.

Key insights

Group gross margins compressing below 45.0% over two consecutive quarters indicates failure to recover packaging and commodity cost inflation.
Regulatory blocking or transaction delay pushing the Foods separation beyond late 2027 demands an immediate review of capital allocation.

Company Financial Analysis

Unilever Earnings and Financials Analysis by AI

Financial figures available as of Sep 20, 2026. Only filings and source records available by this analysis date are included.

Earnings and financials

AI Review

The headline drop in 2025 revenue to 50.5 billion euros reflects the planned separation of the ice cream business rather than falling shopper demand. Looking under the surface, core operating profit rose over five percent to 9.9 billion euros as focused management prioritized thirty high-performing brands. Recent results confirm that sales growth is being driven by healthy volume gains across personal wash and beauty rather than inflationary price hikes. While temporary separation charges and currency fluctuations weigh on reported bottom-line profits, underlying cash generation remains robust, establishing dependable recurring earnings power as corporate simplification proceeds.

Revenue, earnings, and cash flow

The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.

Revenue, net income, and free cash flow history
Fiscal year	Revenue	Net income	Free cash flow
2025	EUR 50.5B	EUR 6B	EUR 6.4B
2024	EUR 60.8B	EUR 5.7B	EUR 7.5B
2023	EUR 59.6B	EUR 6.5B	EUR 7.7B
2022	EUR 60.1B	EUR 7.6B	EUR 5.7B
2021	EUR 52.4B	EUR 6B	EUR 6.7B

Valuation context: historical P/E

The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.

Historical price-to-earnings ratios
Fiscal year	P/E	Earnings basis	Currency basis	Ticker / reporting
2025	12.9x	TTM	USD-normalized	GBX / EUR
2024	11.2x	TTM	USD-normalized	GBX / EUR
2023	16.1x	TTM	USD-normalized	GBX / --
2022	15.8x	Annual	USD-normalized	GBX / EUR
2021	19.8x	Annual	USD-normalized	GBX / EUR

P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.

Profitability and margins

AI Review

Profitability has expanded structurally as management eliminates lower-margin, seasonal businesses. Gross margin climbed to 46.9 percent in 2025, while underlying operating margin reached 20.0 percent, supported by early completion of an eight-hundred-million-euro operational productivity program. This margin expansion reflects lasting operational improvements rather than temporary pricing tricks. Concentrating sales behind thirty premium Power Brands provides strong consumer pricing power against packaging and commodity inflation. By combining cost efficiencies with a richer product mix in personal care, the business protects operating margins and ensures durable through-cycle cash generation.

The table compares up to five fiscal years of operating income and reported profitability margins.

Operating income and margin history
Fiscal year	Operating income	Operating margin	Net margin
2025	EUR 9.9B	19.6%	11.9%
2024	EUR 9.4B	15.5%	9.5%
2023	EUR 9.8B	16.4%	10.9%
2022	EUR 10.8B	17.9%	12.7%
2021	EUR 8.7B	16.6%	11.5%

Balance sheet and leverage

AI Review

The balance sheet is structured for safety and resilience during periods of higher interest rates. Although equity shrank following the ice cream carve-out, operating profits cover interest expenses nearly ten times over, confirming that debt obligations are fully manageable. A low current ratio simply reflects standard consumer staples working capital, where customer cash is collected before suppliers are paid. Looking ahead, fifteen billion dollars in separation cash proceeds will provide substantial flexibility to extinguish debt and fund multi-billion-pound share buybacks without risking investment-grade credit ratings.

The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.

Balance sheet leverage and liquidity history
Fiscal year	Total debt	Cash + short-term investments	Net cash / (debt)	Current ratio
2025	EUR 29.6B	EUR 5.1B	EUR 25.7B net debt	0.79x
2024	EUR 30.7B	EUR 7.6B	EUR 24.5B net debt	0.76x
2023	EUR 28.6B	EUR 6.1B	EUR 24.4B net debt	0.76x
2022	EUR 29.3B	EUR 5.5B	EUR 24.1B net debt	0.75x
2021	EUR 29.7B	EUR 4.5B	EUR 26.3B net debt	0.70x

Net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.

Capex and investment intensity

AI Review

Management has deliberately lowered capital spending on physical factories, trimming capital expenditures to 2.76 percent of turnover in 2025. Exiting asset-heavy cold-chain logistics and frozen manufacturing permanently frees cash that was previously tied up in maintenance equipment. Instead of heavy industrial building, leadership is directing money into high-return areas like premium beauty formulations, factory robotics, and targeted digital advertising. This asset-light approach releases billions of euros in free cash flow, allowing the company to fund substantial dividend payouts and share buybacks while sustaining competitive brand leadership.

The table compares up to five fiscal years of capital expenditure and research-and-development investment.

Capital expenditure and research and development history
Fiscal year	Capital expenditure	R&D spend
2025	EUR 1.4B	EUR 820.9M
2024	EUR 2B	EUR 987M
2023	EUR 1.7B	EUR 949M
2022	EUR 1.6B	EUR 908M
2021	EUR 1.2B	EUR 847M

Immutable published data

Averaged consensus horizons

The table preserves this publication's original rating, return, and advisor-agreement measurements by forecast horizon.

Horizon	Rating	Score incl. dividends	Compounded return incl. dividends	Direction agreement	Snapshot
1Y	BUY	189	+11.9%	Not available	ORIGINAL
5Y	BUY	230	+77.5%	Not available	ORIGINAL

Averaged consensus scenarios

The table outlines the frozen bear, consensus, and bull price scenarios for each published forecast period.

Period	Date	Bear case	Consensus	Bull case	AI Advisors
+3M	December 18, 2026	4,482.37	4,713.42	4,759.63	14
+6M	March 18, 2027	4,616.84	4,858.29	4,950.02	14
+9M	June 18, 2027	4,755.35	4,952.02	5,098.52	14
+1Y	September 18, 2027	4,042.04	4,997.83	5,302.46	14
+15M	December 18, 2027	4,203.73	5,114.39	5,408.51	14
+18M	March 18, 2028	4,287.8	5,254	5,678.93	14
+21M	June 18, 2028	4,416.43	5,366.23	5,849.3	14
+2Y	September 18, 2028	4,328.11	5,461.61	6,083.27	14
+27M	December 18, 2028	4,587.79	5,575.7	6,204.94	14
+30M	March 18, 2029	4,679.55	5,728.19	6,453.13	14
+33M	June 18, 2029	4,819.93	5,834.65	6,646.73	14
+3Y	September 18, 2029	4,916.33	5,948.09	6,846.13	14
+39M	December 18, 2029	5,014.66	6,050.64	6,983.05	14
+42M	March 18, 2030	5,114.95	6,203.71	7,262.37	14
+45M	June 18, 2030	5,268.4	6,310.66	7,480.25	14
+4Y	September 18, 2030	5,373.77	6,424.98	7,704.65	14
+51M	December 18, 2030	5,427.51	6,532.59	7,858.75	14
+54M	March 18, 2031	5,536.06	6,684.13	8,173.1	14
+57M	June 18, 2031	5,646.78	6,796.08	8,418.29	14
+5Y	September 18, 2031	5,759.71	6,922.26	8,670.84	14

Frozen comparison context

SPDR S&P 500 ETF Trust forecast context

The benchmark definition and forecast path are frozen with this publication so future benchmark changes do not rewrite the historical comparison.

Benchmark snapshot: 761.69 on September 18, 2026

Period	Date	Bear case	Consensus	Bull case
+3M	December 18, 2026	723.6055	750.2647	769.3069
+6M	March 18, 2027	701.8973	736.44	784.693
+9M	June 18, 2027	695.1	743.3975	808.2338
+1Y	September 18, 2027	681.198	755.1476	816.3162
+15M	December 18, 2027	688.01	776.2182	840.8057
+18M	March 18, 2028	701.7702	787.1259	857.6218
+21M	June 18, 2028	722.8233	802.8344	883.3504
+2Y	September 18, 2028	730.0515	812.0465	892.1839
+27M	December 18, 2028	751.9531	839.1839	927.8713
+30M	March 18, 2029	766.9921	850.5008	946.4287
+33M	June 18, 2029	782.332	872.3935	965.3573
+3Y	September 18, 2029	790.1553	885.5111	975.0109
+39M	December 18, 2029	805.9584	909.5618	1,004.2612
+42M	March 18, 2030	822.0776	916.132	1,024.3464
+45M	June 18, 2030	830.2984	936.5109	1,055.0768
+4Y	September 18, 2030	830.2984	947.3438	1,065.6276
+51M	December 18, 2030	855.2073	969.5876	1,097.5964
+54M	March 18, 2031	872.3114	979.9863	1,119.5483
+57M	June 18, 2031	889.7577	999.6043	1,141.9393
+5Y	September 18, 2031	898.6553	1,011.7644	1,153.3587

Frozen comparison context

GBPUSD.FOREX forecast context

The batch's original direct_listing_to_usd path is preserved for transparent interpretation of USD-normalized returns.

FX snapshot: 1.34 on September 20, 2026

Period	Date	Bear case	Consensus	Bull case
+3M	December 20, 2026	1.3132	1.3237	1.34
+6M	March 20, 2027	1.2869	1.3096	1.3534
+9M	June 20, 2027	1.2741	1.3087	1.3669
+1Y	September 20, 2027	1.2613	1.3116	1.3669
+15M	December 20, 2027	1.2487	1.3089	1.3806
+18M	March 20, 2028	1.2362	1.3071	1.3801
+21M	June 20, 2028	1.2239	1.3128	1.3939
+2Y	September 20, 2028	1.2361	1.3158	1.4078
+27M	December 20, 2028	1.2359	1.3139	1.4078
+30M	March 20, 2029	1.2361	1.309	1.3937
+33M	June 20, 2029	1.2357	1.3128	1.4076
+3Y	September 20, 2029	1.2234	1.3138	1.4081
+39M	December 20, 2029	1.2234	1.3168	1.4222
+42M	March 20, 2030	1.2236	1.3159	1.4222
+45M	June 20, 2030	1.2232	1.3216	1.4364
+4Y	September 20, 2030	1.211	1.3218	1.4507
+51M	December 20, 2030	1.211	1.3189	1.4362
+54M	March 20, 2031	1.1993	1.3198	1.4506
+57M	June 20, 2031	1.2109	1.3236	1.4506
+5Y	September 20, 2031	1.1991	1.3227	1.4506

The Vulture

Gemini 3.8 Flash

Weight5.0/100

The report provides diligent forensic scrutiny of working capital, debt maturity profiles, and productivity savings under leadership changes. However, it ignores the Foods carve-out entirely and unhelpfully incorporates unadjusted, currency-mismatched cash flow figures, limiting its path reliability over the five-year horizon.

AI THINKER

Superintelligence AI

The Anthropologist

Gemini 3.8 Flash

Weight4.0/100

While soundly identifying defensive hygiene demand and core pricing elasticity, this perspective leans heavily on biological metaphors and relies on flawed unadjusted cash flow aggregates. Crucially, it completely overlooks the agreed Foods division divestment and its structural effect on the quoted share price.

AI RESEARCHER

Niccolo Machiavelli AI

The Insider

Gemini 3.8 Flash

Weight3.0/100

This perspective correctly identifies governance pressures and administrative cost pruning under board restructuring. However, its thesis hinges primarily on monetizing the retained ice cream stake while completely missing the agreed Foods transaction, thereby mischaracterizing future portfolio composition and capital returns.

AI THINKER

Warren Buffett AI

The Value Seeker

Gemini 3.8 Flash

Weight2.0/100

Although offering sound classical insights on brand moats and pricing power, this submission severely errs by uncritically adopting unadjusted trailing figures of fourteen billion dollars in free cash flow. Furthermore, omitting the agreed Foods divestiture renders its long-term valuation trajectory unreliable.

AI RESEARCHER

Warren Buffett AI

The Value Seeker

Gemini 3.8 Flash

Weight2.0/100

This report accurately details productivity gains and volume stabilization in core hygiene brands. However, it duplicates flawed trailing free cash flow metrics and completely ignores the transformational Foods agreement, resulting in an unadjusted path that fails to reflect corporate perimeter shifts.

Skip to references

Research Provenance

References & Context

This Unilever consensus analysis combines structured market evidence with independent AI-agent forecasts. External references below are limited to sources recorded by the researcher agents for this forecast batch.

Primary analysis inputs

iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.

Independent AI Advisor panel

AI Advisors: 14
AI Researchers: 11
AI Thinkers: 3

Sources retained from AI Researcher searches

Asset-specific · Researcher web

Showing the top 15 of 51 deduplicated sources retained for this batch.

01https://www.sec.gov/Archives/edgar/data/217410/000165495426001155/a6773s.htm?utm_source=openaisec.gov
02https://www.sec.gov/Archives/edgar/data/217410/000199937126015710/mkcv-425_072326.htm?utm_source=openaisec.gov
03mkc-20260228sec.gov
04ul-20251231sec.gov
05ul-20260630sec.gov
06ul-20260630sec.gov
07UNILEVER PLC - Form 425 - FY2026sec.gov
08UNILEVER PLC - Form 6-K - FY2026sec.gov
09UNILEVER PLC - Form 6-K - FY2026sec.gov
102026 First Half Results Desire at Scale powering strong H1 performanceunilever.com
11ULVR Stock Forecast - Unilever PLC - Alpha Spreadalphaspread.com
12Unilever PLC (ULVR) stock price prediction 2026–2030bitget.com
13Unilever H1 2026 slides: volume growth accelerates to 5.5% in Q2 By Investing.comca.investing.com
14McCormick buys Unilever's food business in deal that values it at nearly $45 billioncnbc.com
15Unilever plc (via Public) / Building resilience, driving growth: inside Unilever’s AI-powered supply chainebs.publicnow.com

And 36 more sources were used and retained in the batch inventory.

Context retained with this Consensus

The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.

Global context snapshot

2025 Full-Year Global Market and World-Events Context

Download Archived Snapshot

Coverage 2025-01-01 to 2025-12-31 · Knowledge cutoff 2025-12-31

This full-year context package covers the principal geopolitical, economic, monetary-policy, technology, trade, energy, and institutional developments that shaped global markets during 2025. It gives the forecasting model a chronological account of major world events together with their likely transmission into growth, inflation, interest rates, supply chains, commodities, currencies, public markets, and sector-level investment conditions.

The package also includes monthly and quarterly macroeconomic and cross-asset reference tables spanning US and international growth, central-bank policy, sovereign yields, major equity indices, foreign exchange, energy, industrial and precious metals, and digital assets. Quarterly and full-year high-impact summaries are integrated; monthly quantitative series remain working values pending final audit, and that qualification is part of the preserved context.

Top 3 market shifts from 2025 Full-Year Global Market and World-Events Context
Top 3 Market Shifts From File	Date	Status
DeepSeek shock and AI economics reset	2025-01-27	OPEN ENDED TREND
US tariff regime escalation and trade-system rupture	2025-02-01	ACTIVE POLICY REGIME
Federal Reserve easing cycle after a prolonged hold	2025-09-17	ACTIVE POLICY REGIME

Representative Sources of the Context File

Federal Reserve US Bureau of Labor Statistics US Bureau of Economic Analysis US Treasury US Energy Information Administration Reuters World Associated Press World News BBC World

And more sources from the retained context package.

2026 Year-to-Date Global Market and World-Events Context Through September 20

Download Archived Snapshot

Coverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20

January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.

Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.

Top 3 market shifts from 2026 Year-to-Date Global Market and World-Events Context Through September 20
Top 3 Market Shifts From File	Date	Status
Renewed monetary tightening amid persistent inflation	2026-01-30	ACTIVE POLICY REGIME
Iran/Hormuz conflict and wider energy-security disruption	2026-02-28	ONGOING
Tariff legal reset and strategic supply restrictions	2026-02-20	ACTIVE POLICY REGIME

Representative Sources of the Context File

Federal Reserve US Bureau of Labor Statistics European Central Bank International Monetary Fund Reuters World Associated Press World News

And more sources from the retained context package.

Fundamental context

Income statement

9 fields

depreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields

Balance sheet

12 fields

cash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields

Cash flow

5 fields

capitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field

annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 8 periods

Currencies cited: EUR, GBP, GBX, USD (quote GBX; primary reporting EUR; converted/valuation USD; normalization GBP).

End of the paywalled preview

The excerpt from Deep Dive to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Additional with full access

Individual AI Advisor reports
- Separate investment theses, scenarios, factors, risks and opportunities
- Quarterly forecast events and supporting citations
- Published advisor configuration snapshots
Interactive research tools
- Zoomable forecast and benchmark comparisons
- Currency and dividend assumptions
- Additional datasets and eligible historical research

Explore complete public research examples

These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.